• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性淋巴细胞白血病患者中,白血病细胞的生物学和遗传学特征对Sysmex XN血液分析仪WPC通道散点图中“鲨鱼鳍”出现情况的影响。

Impact of biological and genetic features of leukemic cells on the occurrence of "shark fins" in the WPC channel scattergrams of the Sysmex XN hematology analyzers in patients with chronic lymphocytic leukemia.

作者信息

Egger Margot, Fang I-Fei, Quehenberger Franz, Robier Christoph

机构信息

Department of Laboratory Medicine, Konventhospital Barmherzige Brueder Linz and Ordensklinikum Linz, Linz, Austria.

Medical Faculty, Johannes Kepler University Linz, Linz, Austria.

出版信息

Clin Chem Lab Med. 2025 Mar 17;63(7):1427-1431. doi: 10.1515/cclm-2025-0115. Print 2025 Jun 26.

DOI:10.1515/cclm-2025-0115
PMID:40084841
Abstract

OBJECTIVES

In patients with chronic lymphocytic leukemia (CLL), the white progenitor cell (WPC) channel of the Sysmex XN hematology analyzers typically shows a varying proportion of cells in the upper left field of the scattergram, resembling the shape of shark fins. The underlying mechanism causing this phenomenon has not been elucidated so far. In this study we evaluated biological and/or genetic features of CLL cells as a potential background of the "shark fins".

METHODS

Automated blood counts and WPC scattergrams of 95 CLL patients were analyzed. The scattergrams were examined for the presence, count and percentage of cells in the "shark fins" using a flow cytometry software. Potential influencing factors on the occurrence of the "shark fin" cells were statistically tested by Spearman correlation.

RESULTS

The lymphocyte count was identified as a highly statistically significant predictor of "shark fins" (p<0.0001). Absence of del(17p) (p=0.02), unmutated TP53 (p=0.01), mutated IGHV (p=0.03) and the percentage of smudge cells in peripheral blood smears (p=0.04) showed a statistically significant positive influence on the percentage of cells in the "shark fins" after adjustment for the lymphocyte count. No significant effect was observed for age, sex, del(13q), del(11q), trisomy 12 and treatment.

CONCLUSIONS

We identified the lymphocyte count, the absence of TP53 mutations and del(17p), a mutated IGHV and the proportion of smudge cells as significant influences on the appearance of "shark fin" cells. Our findings indicate an impact of biological and genetic properties of the leukemic cells on the formation of "shark fins".

摘要

目的

在慢性淋巴细胞白血病(CLL)患者中,Sysmex XN血液分析仪的白细胞祖细胞(WPC)通道在散点图的左上方区域通常显示不同比例的细胞,类似鱼鳍的形状。迄今为止,导致这种现象的潜在机制尚未阐明。在本研究中,我们评估了CLL细胞的生物学和/或遗传学特征,作为“鱼鳍”现象的潜在背景。

方法

分析了95例CLL患者的自动血细胞计数和WPC散点图。使用流式细胞术软件检查散点图中“鱼鳍”内细胞的存在情况、计数和百分比。通过Spearman相关性对“鱼鳍”细胞出现的潜在影响因素进行统计学检验。

结果

淋巴细胞计数被确定为“鱼鳍”现象具有高度统计学意义的预测指标(p<0.0001)。在调整淋巴细胞计数后缺失del(17p)(p=0.02)、未突变的TP53(p=0.01)、突变的IGHV(p=0.03)以及外周血涂片上涂抹细胞的百分比(p=0.04)对“鱼鳍”内细胞的百分比显示出统计学上显著的正影响。未观察到年龄、性别、del(13q)、del(11q)、三体12和治疗有显著影响。

结论

我们确定淋巴细胞计数、TP53突变和del(17p)的缺失、IGHV突变以及涂抹细胞的比例对“鱼鳍”细胞的出现有显著影响。我们的研究结果表明白血病细胞的生物学和遗传学特性对“鱼鳍”的形成有影响。

相似文献

1
Impact of biological and genetic features of leukemic cells on the occurrence of "shark fins" in the WPC channel scattergrams of the Sysmex XN hematology analyzers in patients with chronic lymphocytic leukemia.慢性淋巴细胞白血病患者中,白血病细胞的生物学和遗传学特征对Sysmex XN血液分析仪WPC通道散点图中“鲨鱼鳍”出现情况的影响。
Clin Chem Lab Med. 2025 Mar 17;63(7):1427-1431. doi: 10.1515/cclm-2025-0115. Print 2025 Jun 26.
2
Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.12号染色体三体、13号染色体长臂缺失、17号染色体短臂缺失及11号染色体长臂缺失对慢性淋巴细胞白血病中白血病B细胞免疫表型、DNA倍体状态及增殖率的影响
Cytometry B Clin Cytom. 2008 May;74(3):139-49. doi: 10.1002/cyto.b.20390.
3
Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia.剖析 TP53 改变在 del(11q) 慢性淋巴细胞白血病中的作用。
Clin Transl Med. 2021 Feb;11(2):e304. doi: 10.1002/ctm2.304.
4
The Heterogeneity of 13q Deletions in Chronic Lymphocytic Leukemia: Diagnostic Challenges and Clinical Implications.慢性淋巴细胞白血病中13q缺失的异质性:诊断挑战与临床意义
Genes (Basel). 2025 Feb 22;16(3):252. doi: 10.3390/genes16030252.
5
The percentage of cells with 17p deletion and the size of 17p deletion subclones show prognostic significance in chronic lymphocytic leukemia.17p 缺失细胞的百分比和 17p 缺失亚克隆的大小在慢性淋巴细胞白血病中具有预后意义。
Genes Chromosomes Cancer. 2019 Jan;58(1):43-51. doi: 10.1002/gcc.22692. Epub 2018 Nov 29.
6
Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia.常规血涂片上确定的有核红细胞百分比是慢性淋巴细胞白血病的一种新的预后因素。
Leuk Res. 2010 Jul;34(7):892-8. doi: 10.1016/j.leukres.2010.02.038. Epub 2010 Mar 29.
7
Clinical, immunophenotypic, and molecular profiling of trisomy 12 in chronic lymphocytic leukemia and comparison with other karyotypic subgroups defined by cytogenetic analysis.慢性淋巴细胞白血病中12号染色体三体的临床、免疫表型及分子特征分析,并与细胞遗传学分析定义的其他核型亚组进行比较。
Cancer Genet Cytogenet. 2006 Jul 15;168(2):109-19. doi: 10.1016/j.cancergencyto.2006.02.001.
8
TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病患者白血病细胞上的 TLR2 表达。
Arch Immunol Ther Exp (Warsz). 2019 Feb;67(1):55-65. doi: 10.1007/s00005-018-0523-9. Epub 2018 Sep 8.
9
Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax.奥滨尤妥珠单抗联合维奈克拉治疗 CLL 患者的遗传标志物的预后和预测影响。
Blood. 2020 Jun 25;135(26):2402-2412. doi: 10.1182/blood.2019004492.
10
Prognostic and predictive significance of smudge cell percentage on routine blood smear in chronic lymphocytic leukemia.慢性淋巴细胞白血病常规血涂片上涂抹细胞百分比的预后及预测意义
Clin Lymphoma Myeloma Leuk. 2014 Dec;14(6):514-7. doi: 10.1016/j.clml.2014.02.007. Epub 2014 Feb 18.

本文引用的文献

1
Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures.慢性淋巴细胞白血病:诊断与治疗程序的 2022 年更新。
Am J Hematol. 2021 Dec 1;96(12):1679-1705. doi: 10.1002/ajh.26367.
2
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.iwCLL 指南:用于 CLL 的诊断、治疗指征、疗效评估和支持性管理。
Blood. 2018 Jun 21;131(25):2745-2760. doi: 10.1182/blood-2017-09-806398. Epub 2018 Mar 14.
3
Performance of the XN-2000 WPC channel-flagging to differentiate reactive and neoplastic leukocytosis.
XN-2000 WPC 通道标记对反应性和肿瘤性白细胞增多的鉴别性能。
Clin Chem Lab Med. 2016 Sep 1;54(9):1503-10. doi: 10.1515/cclm-2015-1105.
4
Comparison of optical data from flow cytometry and microscopy of leukocytes after exposure to specific reagents.暴露于特定试剂后白细胞的流式细胞术和显微镜光学数据比较。
Microscopy (Oxf). 2015 Oct;64(5):305-10. doi: 10.1093/jmicro/dfv023. Epub 2015 May 25.
5
Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis.慢性淋巴细胞白血病诊断与预后的分子基础
Cell Oncol (Dordr). 2015 Apr;38(2):93-109. doi: 10.1007/s13402-014-0215-3. Epub 2015 Jan 7.
6
Performance evaluation of the new hematology analyzer Sysmex XN-series.新型血液分析仪Sysmex XN系列的性能评估
Int J Lab Hematol. 2015 Apr;37(2):155-64. doi: 10.1111/ijlh.12254. Epub 2014 May 12.
7
Molecular pathogenesis of chronic lymphocytic leukemia.慢性淋巴细胞白血病的分子发病机制。
J Clin Invest. 2012 Oct;122(10):3432-8. doi: 10.1172/JCI64101. Epub 2012 Oct 1.
8
Clinical and laboratory prognostic indicators in chronic lymphocytic leukemia.慢性淋巴细胞白血病的临床和实验室预后指标。
Cancer Control. 2012 Jan;19(1):18-25. doi: 10.1177/107327481201900103.
9
Practice guidelines on the reporting of smudge cells in the white blood cell differential count.白细胞分类计数中涂抹细胞报告的实践指南。
Arch Pathol Lab Med. 2003 Jan;127(1):105. doi: 10.5858/2003-127-105-PGOTRO.
10
Rigidity of circulating lymphocytes is primarily conferred by vimentin intermediate filaments.循环淋巴细胞的刚性主要由波形蛋白中间丝赋予。
J Immunol. 2001 Jun 1;166(11):6640-6. doi: 10.4049/jimmunol.166.11.6640.